Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Richardus, J. H
Right arrow Articles by Smith, W C. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardus, J. H
Right arrow Articles by Smith, W C. S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Volume 33, Number 2, pp. 337-343
IJE vol.33 no.2 © International Epidemiological Association 2004; all rights reserved.


Article

Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up

Jan H Richardus1, Peter G Nicholls2, Richard P Croft3, Stephen G Withington3 and W Cairns S Smith2

1 Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
2 Department of Public Health, University of Aberdeen, Aberdeen, UK
3 The Danish Bangladesh Leprosy Mission (DBLM), Nilphamari, Bangladesh

Correspondence: Dr JH Richardus, Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail: j.richardus{at}erasmusmc.nl

Background Nerve function impairment (NFI) is the key outcome of the pathological processes of infection with Mycobacterium leprae, which can continue after completion of multidrug therapy (MDT) and lead to disability after leprosy patients are released from treatment. The objective of this study was to assess the need for and duration of surveillance of NFI.

Methods Prospective cohort study of 2664 new leprosy patients in Bangladesh, with an observation period of 36 months in paucibacillary (PB) patients, and 60 months in multibacillary (MB) patients. Incidence rates (IR) were calculated with the number of patients developing NFI, type 1 and type 2 reactions, and silent neuritis for the first time after registration as the numerator, and cumulative person-years at risk (PYAR) as the denominator. Survival curves to the first event of NFI were also calculated.

Results The IR of first event of NFI amongst MB patients was 16.1 per 100 PYAR, with 121/357 (34%) developing NFI during the observation period. Of the 121 with a first event of NFI, 77 (64%) had this within a year after registration, 35 (29%) in the second year, and the remaining 9 (7%) after 2 years. The IR of first event of NFI amongst PB patients was 0.9 per 100 PYAR, with 54/2153 (2.5%) developing NFI during the observation period. Of the 54 with a first event of NFI, 48 (89%) had this within a year after registration, 3 (5.5%) in the second year, and the remaining 3 (5.5%) cases after 2 years. The percentage of PB patients with no NFI at registration surviving without developing NFI during the observation period was 99% and for PB patients with NFI at registration 92%. In MB patients without NFI at registration, the percentage surviving with no NFI during the observation period was 84% and for MB patients with NFI at registration only 36%.

Conclusion New episodes of NFI and reactions after registration are common, in particular in MB patients with long-standing NFI at registration. The study highlights the importance of continuing surveillance for NFI of this risk group after registration for 2 years. Active surveillance beyond 2 years is not indicated.


Keywords Leprosy epidemiology, peripheral nerve disease

Accepted 2 May 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J OphthalmolHome page
E Daniel, T J ffytche, J H Kempen, P S S Sundar Rao, M Diener-West, and P Courtright
Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy
Br J Ophthalmol, August 1, 2006; 90(8): 949 - 954.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. M. Scollard, L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams
The Continuing Challenges of Leprosy
Clin. Microbiol. Rev., April 1, 2006; 19(2): 338 - 381.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
N. Marano and B. Plikaytis
Commentary: Strategic surveillance--key to attainment of leprosy control and elimination goals at the local level
Int. J. Epidemiol., April 1, 2004; 33(2): 349 - 350.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.